Cellcept (mycophenolate mofetil) for patients with antibody-negative myasthenia gravis; is it worth a trial?

Yes. It is not clear exactly how the autoantibodies work. Antibody identification may not be 100 % and there may be other antibodies that have not been detected. Depending on what therapy has been tried CellCept (mycophenolate mofetil) may be appropriate. This is best discussed with your physician.

Related Questions

I have for years taken mycophenolate mofetil (1 gram per day) and prednisone (10 mgs per day alternating with 15 mg per day) for Myasthenia Gravis. I?

Immunosuppressives. Both of these drugs are immunosuppressive drugs which can weaken the immune system while the disease is being controlled. They both require monitoring. In the long run, prednisone may be associated with more side effects. Be sure to discuss any concerns with your neurologist.